VEGF, VEGFR3, and PDGFRB Protein Expression Is Influenced by <i>RAS</i> Mutations in Medullary Thyroid Carcinoma
Veronika Mančíková(Centro de Biología Molecular Severo Ochoa), Mercedes Robledo(The University of Texas at San Antonio Health Science Center), María Currás-Freixes(Spanish National Cancer Research Centre), María Apellániz-Ruiz(Navarrabiomed), Aguirre A. de Cubas(Medical University of South Carolina), Cristina Rodríguez‐Antona(Instituto de Salud Carlos III), Álvaro Gómez(Spanish National Cancer Research Centre), Iris Kersten(Spanish National Cancer Research Centre), Lara M. Munín Sánchez(Spanish National Cancer Research Centre), Juan F. Garcı́a(MD Anderson Cancer Center Madrid), Lucía Inglada‐Pérez(Spanish National Cancer Research Centre), Alberto Cascón(Spanish National Cancer Research Centre), Iñaki Comino‐Méndez(Breast Cancer Now), Rocío Letón, Júlia Sastre-Marcos(Hospital Virgen de la Salud), Luis J. Leandro‐García(Spanish National Cancer Research Centre)
Cited by 19
Related Papers
The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma
|Cell Reports|2018|818
Comprehensive Molecular Characterization of Pheochromocytoma and Paraganglioma
|Cancer Cell|2017|791
Exome sequencing identifies MAX mutations as a cause of hereditary pheochromocytoma
|Nature Genetics|2011|528
Assessment of Molecular Relapse Detection in Early-Stage Breast Cancer
|JAMA Oncology|2019|425